Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2023-10-16 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
董事会提名委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the 'Board Nomination Committee Working Rules' of Zhejiang Tailin Biotechnology Co., Ltd. It details the structure, responsibilities, procedures, and rules governing the board nomination committee. There is no financial data, no mention of financial results, no voting results, no announcements of reports, or any other regulatory filings. The content is focused on governance practices related to board nominations and committee operations. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 2513 characters, which is sufficient for a detailed governance document but too short for a full annual or interim report. Therefore, the classification is Governance Information (CGR) with high confidence.
2023-10-16 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled "董事会议事规则" which translates to "Board Meeting Rules" or "Rules of Procedure for the Board of Directors". It details the structure, responsibilities, meeting procedures, decision-making processes, and duties of the board of directors of the company 浙江泰林生物技术股份有限公司. The content is focused on governance practices, board composition, meeting protocols, and decision authority, rather than financial results, audit opinions, or shareholder meeting materials. There is no indication of financial data, audit reports, or voting results. The document is a governance framework outlining internal rules and board operations, which fits the definition of Governance Information (CGR). The document length is substantial and contains detailed governance rules, not a brief announcement or a report publication notice. Therefore, the appropriate classification is Governance Information (CGR).
2023-10-16 Chinese
关于董事会提议向下修正“泰林转债”转股价格的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding a proposal by the board of directors to downward adjust the conversion price of the company's convertible bonds ("Tailin Convertible Bonds"). It details the background of the convertible bonds issuance, previous adjustments to the conversion price, the conditions triggering the current proposed downward adjustment, and the procedural requirements including shareholder approval. The document is a formal announcement of a corporate action related to convertible bonds and capital structure, specifically a proposal for a price adjustment to be voted on at a shareholders' meeting. It does not contain financial statements, audit results, or detailed financial performance data. It is not a full report but an announcement of a capital/financing update related to convertible bonds. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is under 5,000 characters and it is not merely announcing the publication of a report but is itself the announcement of a financing-related corporate action.
2023-10-16 Chinese
股东大会议事规则
Governance Information Classification · 100% confidence The document is titled as the "Shareholders' Meeting Rules" of Zhejiang Tailin Biotechnology Co., Ltd. It extensively details the procedures, rules, and regulations governing the conduct of shareholders' meetings, including the convening, proposal submission, voting, and other operational aspects of the shareholders' meetings. There is no financial data, earnings information, or report content. Instead, it is a governance document outlining internal rules and procedures related to corporate governance and shareholder meetings. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-10-16 Chinese
董事会审计委员会工作细则
Governance Information Classification · 95% confidence The document is titled '董事会审计委员会工作细则' which translates to 'Board Audit Committee Working Rules'. It details the structure, responsibilities, and procedures of the audit committee within the board of directors of the company. It includes sections on personnel composition, duties, decision-making procedures, meeting rules, and other governance-related content. There is no financial data, no audit report results, no financial statements, nor any announcement of financial results or voting outcomes. The document is a governance-related internal rules document about the audit committee's operation and oversight functions. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-10-16 Chinese
独立董事专门会议工作制度
Governance Information Classification · 95% confidence The document is titled '独立董事专门会议工作制度' which translates to 'Independent Directors Special Meeting Work System'. It outlines the governance rules and procedures for independent directors' meetings within the company, including their duties, meeting frequency, decision-making processes, and confidentiality obligations. The content focuses on internal governance practices and board structure rather than financial results, audit opinions, or shareholder voting outcomes. It does not contain financial data or report on financial performance. This aligns with the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-10-16 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.